Leukemia, Myelodysplasia, Transplantation
News
Discovery could help predict, prevent therapy-related AML
Credit: Rhoda Baer A new study challenges the view that cancer treatment is a direct cause of therapy-related acute myeloid leukemia (AML). The...
Conference Coverage
First randomized evidence for kinase inhibitor use in AML
Photo courtesy of ASH SAN FRANCISCO—Researchers have presented the first randomized evidence that kinase inhibitors are effective in the...
News
FDA approves drug for HCM
HCM results from cancer-driven increases in bone resorption.
Conference Coverage
More isn’t always better with daunorubicin induction in AML
Photo courtesy of ASH SAN FRANCISCO—Results regarding daunorubicin escalation in induction for patients with acute myeloid leukemia (AML) have...
News
Encapsulating doxorubicin can reduce heart damage
Credit: USDA VIENNA—Encapsulating the anthracycline doxorubicin in a liposome can reduce the risk of developing heart damage, according to a...
Conference Coverage
CLL drug can fight AML too, study suggests
Credit: FDA SAN FRANCISCO—A BCL2 inhibitor that previously proved active against chronic lymphocytic leukemia has shown activity in certain...
News
Disordered methylation compromises CLL treatment
Credit: Christoph Bock New research suggests disordered methylation is one of the defining characteristics of cancer and helps tumors adapt to...
News
Finding could help docs tailor treatment for myeloid leukemias
PHILADELPHIA—New research suggests that stiffness in the extracellular matrix (ECM) can predict how leukemias will respond to therapy. Using a 3D...
Conference Coverage
Sorafenib boosts event-free survival of adult AML
Key clinical point: This study is the first randomized trial to show efficacy of kinase inhibition in AML. Major finding: 3-year event-free...
Conference Coverage
Young adults with ALL have better survival with pediatric regimens
Key clinical point: Adolescents and young adults with acute lymphoblastic leukemia should be treated with a pediatric rather than an adult ALL...
News
Mouse model reveals insight into CLL relapse
Researchers say they have discovered why patients with chronic lymphocytic leukemia (CLL) often relapse. Using a mouse model, the team...